ARKK Holdings of NVS
Novartis
Novartis International AG is a global healthcare company that specializes in the development, manufacture, and marketing of a broad range of pharmaceutical and medical products. Novartis generates revenue primarily by selling prescription medications across various therapeutic areas, including oncology, immunology, and ophthalmology, as well as through its generics division, Sandoz.
Trades of NVS in ARKK
The ten most recent trades of Novartis in the ARKK ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jul 23, 2021 | Sell | $19,801 | 100.00% | 0.00% |
| Jul 22, 2021 | Sell | $255,450 | 1,296.30% | 0.00% |
| Jul 21, 2021 | Sell | $898,850 | 327.12% | 0.00% |
| Jul 20, 2021 | Sell | $3,614,000 | 310.53% | 0.02% |
| Jul 19, 2021 | Sell | $7,376,232 | 155.71% | 0.03% |
| Jul 16, 2021 | Sell | $23,514,570 | 193.33% | 0.11% |
| Jul 15, 2021 | Sell | $16,785,568 | 47.18% | 0.08% |
| Jul 13, 2021 | Sell | $6,928,991 | 12.83% | 0.03% |
| Jul 12, 2021 | Sell | $11,263,878 | 18.30% | 0.05% |
| Jul 09, 2021 | Sell | $6,589,871 | 9.16% | 0.03% |